Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Histologic Type × ricolinostat × 30 days × Clear all

Sponsor

Interventions

repotrectinib 1 gilteritinib 1 fludarabine 1 durvalumab 1 Immunotherapy 1 Idarubicin 1 Granulocyte Colony-Stimulating Factor 1 Cytarabine 1 Biopsy 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡